Indrayani Biotech Issues ISIN for Rights Issue to Fund Growth

Indrayani Biotech Limited has issued ISIN INE007C20013 for its upcoming rights issue of partly paid equity shares. This administrative step moves the company closer to raising capital. The shares will carry a Rs. 10 face value and a paid-up value of Rs. 2.50 each.

Formal Announcement Details

The company's Right Issue Committee had previously approved key terms on April 9, 2026. The announcement, dated April 21, 2026, formally declares the ISIN INE007C20013, adhering to SEBI regulations and signaling progress in the capital-raising process.

Significance of the ISIN

Declaring the ISIN is a vital administrative step preceding the rights issue's opening. It confirms the company's intention to raise funds from its existing shareholders. This capital is expected to support business expansion, debt reduction, or working capital needs, although the specific allocation is not detailed in the filing.

Company Background

Indrayani Biotech Ltd operates within the agro-products and processed food sector, with a focus on onion and garlic products and related exports.

Impact on Company and Shareholders

The assignment of a formal ISIN for the rights entitlement will facilitate the trading of these entitlements. The company is proceeding with its plan to raise funds from shareholders. Existing shareholders will soon receive entitlement letters, enabling them to subscribe to the new shares. The market will now look for further details on the issue price, record date, and subscription period.

Potential Risks

Key risks to monitor include market acceptance of the partly paid shares and the overall subscription level achieved. There is also potential for earnings per share dilution if the issue is fully subscribed but the raised capital does not generate immediate returns.

Industry Context

Peers such as Mrs. Bectors Food Specialities and Heritage Foods also operate in consumer products and food processing. While in a similar sector, these companies may have different financial structures and growth strategies. Indrayani Biotech's rights issue is aimed at strengthening its financial position, a common approach in the industry to fund expansion or facility upgrades.

Rights Issue Details

• Face Value per Share: Rs. 10
• Paid-up Value per Share: Rs. 2.50
• Announcement Date: April 21, 2026

Next Steps for Investors

Investors and the market will track the announcement of the rights issue price and the exact entitlement ratio. Further key dates include the official opening and closing of the subscription period. Management commentary on how the raised funds will be used, shareholder response, subscription levels, and the subsequent listing of new partly paid-up shares will also be important indicators.